Back
Arcturus Therapeutics Holdings Quote, Financials, Valuation and Earnings
Sponsored
ARCT
Sponsored
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More
Buy
57
ARCT
Arcturus Therapeutics Holdings
Last Price:
24.73
Seasonality Move:
-7.1%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Arcturus Therapeutics Holdings Price Quote
$24.73
-0.75 (-2.94%)
(Updated: October 3, 2024 at 6:55 PM ET)
Arcturus Therapeutics Holdings Key Stats
Buy
57
Arcturus Therapeutics Holdings (ARCT)
is a Buy
Day range:
$24.57 - $25.88
52-week range:
$17.52 - $45.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.65
P/B ratio:
2.66%
Volume:
400.6K
Avg. volume:
374.4K
1-year change:
-0.7%
Market cap:
$689M
Revenue:
$157.7M
EPS:
$-2.57
How Much Does Arcturus Therapeutics Holdings Make?
-
How Much Are Arcturus Therapeutics Holdings's Sales Annually?
ARCT Revenues are $157.7M -
How Much Profit Does Arcturus Therapeutics Holdings's Make A Year?
ARCT net income is -$29.7M
Is Arcturus Therapeutics Holdings Growing As A Company?
-
What Is Arcturus Therapeutics Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is 3.81% -
What Is Arcturus Therapeutics Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Arcturus Therapeutics Holdings Stock Price Performance
-
Did Arcturus Therapeutics Holdings Stock Go Up Last Month?
Arcturus Therapeutics Holdings share price went up by 20.76% last month -
Did ARCT's Share Price Rise Over The Last Year?
ARCT share price fell by -0.7% over the past 1 year
What Is Arcturus Therapeutics Holdings 52-Week High & Low?
-
What Is Arcturus Therapeutics Holdings’s 52-Week High Share Price?
Arcturus Therapeutics Holdings has traded as high as $45.00 over the past 52 weeks -
What Is Arcturus Therapeutics Holdings’s 52-Week Low Share Price?
Arcturus Therapeutics Holdings has traded as low as $17.52 over the past 52 weeks
Arcturus Therapeutics Holdings Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Arcturus Therapeutics Holdings?
-
How Much Debt Does Arcturus Therapeutics Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Arcturus Therapeutics Holdings Have?
Cash and short term investments quarterly total is $260.3M -
What Is Arcturus Therapeutics Holdings’s Book Value Per Share?
Book value per share is 9.56
Is Arcturus Therapeutics Holdings Cash Flow Positive?
-
What Is ARCT Cash Flow From Operations?
Cash flow from operations (TTM) is -$68.7M -
What Is Arcturus Therapeutics Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is $7.8M -
What Is Arcturus Therapeutics Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.4M
Arcturus Therapeutics Holdings Return On Invested Capital
-
Is Management Doing A Good Job?
ARCT return on invested capital is -25.96% -
What Is Arcturus Therapeutics Holdings Return On Assets?
ROA measures how assets are converting to revenues and is -16.93% -
What Is ARCT Return On Equity?
ROE is a measure of profitability and is -26.34%
Arcturus Therapeutics Holdings Earnings Date & Stock Price
-
What Is Arcturus Therapeutics Holdings's Stock Price Today?
A single share of ARCT can be purchased today for 25.48 -
What Is Arcturus Therapeutics Holdings’s Stock Symbol?
Arcturus Therapeutics Holdings trades on the nasdaq under the ticker symbol: ARCT -
When Is Arcturus Therapeutics Holdings’s Next Earnings Date?
The next quarterly earnings date for Arcturus Therapeutics Holdings is scheduled on November 14, 2024 -
When Is ARCT's next ex-dividend date?
Arcturus Therapeutics Holdings's next ex-dividend date is May 15, 2020 -
How To Buy Arcturus Therapeutics Holdings Stock?
You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Arcturus Therapeutics Holdings Competitors
-
Who Are Arcturus Therapeutics Holdings's Competitors?
Below is a list of companies who compete with Arcturus Therapeutics Holdings or are related in some way:
Arcturus Therapeutics Holdings Dividend Yield
-
What Is ARCT Dividend Yield?
Arcturus Therapeutics Holdings’s dividend yield currently is 0% -
What Is Arcturus Therapeutics Holdings’s Payout Ratio?
Arcturus Therapeutics Holdings’s payout ratio is 0% -
When Did Arcturus Therapeutics Holdings Last Pay A Dividend?
The latest dividend pay date is October 4, 2024 -
What Is Arcturus Therapeutics Holdings’s Dividend Per Share?
Arcturus Therapeutics Holdings pays a dividend of $0.00 per share
Arcturus Therapeutics Holdings Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 59.23% |
Revenue: | 380.67% | 124.25% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 77.26 |
Upside from Last Price: | 203.23% |